Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27147585 | 0.93 | CYP17A1 (0.34) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL760246 | 0.91 | ESR1 (0.52) | ESR1PDCD1ESR2CD274NFKB1 | |
| SCHEMBL927965 | 0.89 | ESR1 (0.30) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL928392 | 0.89 | ESR1 (0.30) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL27866274 | 0.89 | CYP1A2 (0.35) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL929334 | 0.89 | ESR1 (0.30) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL27849335 | 0.89 | ACACB (0.33) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL22551505 | 0.89 | ESR1 (0.30) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL22551470 | 0.89 | ESR1 (0.30) | ESR1PDCD1ESR2CD274 | |
| SCHEMBL140535 | 0.87 | TRPA1 (0.39) | ALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026090506-A1 | MEDICAL DEVICE COATINGS AND METHODS | SURMODICS, INC. (US) | 2026-04-30 | — | — | WO | claimed |
| EP-4569015-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | Promega Corporation (US) | 2025-06-18 | — | — | EP | claimed |
| US-20240059961-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | PROMEGA CORPORATION | 2024-02-22 | — | — | US | claimed |
| WO-2024036277-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | PROMEGA CORPORATION (US) | 2024-02-15 | — | — | WO | claimed |
| WO-2022261559-A9 | ANTIFOULING MATERIALS, COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2023-11-30 | — | — | WO | claimed |
| US-20190015815-A1 | SUPERFICIALLY POROUS MATERIALS COMPRISING A COATED CORE HAVING NARROW PARTICLE SIZE DISTRIBUTION; PROCESS FOR THE PREPARATION THEREOF; AND USE THEREOF FOR CHROMATOGRAPHIC SEPARATIONS | WATERS TECHNOLOGIES CORPORATION | 2019-01-17 | — | — | US | claimed |
| EP-3426388-A1 | SUPERFICIALLY POROUS MATERIALS COMPRISING A COATED CORE HAVING NARROW PARTICLE SIZE DISTRIBUTION; PROCESS FOR THE PREPARATION THEREOF; AND USE THEREOF FOR CHROMATOGRAPHIC SEPARATIONS | Waters Technologies Corporation (US) | 2019-01-16 | — | — | EP | claimed |
| EP-2971324-B1 | MICROWAVE INITIATION FOR DEPOSITION OF POROUS ORGANOSILICATE MATERIALS ON FABRICS | US GOV SEC NAVY (US) | 2018-01-31 | — | — | EP | claimed |
| US-9689111-B2 | Microwave initiation for deposition of porous organosilicate materials on fabrics | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2017-06-27 | — | — | US | claimed |
| EP-2850140-B1 | RADIATION CURABLE COMPOSITION, AND METHOD FOR PREPARING A HYBRID SOL-GEL LAYER ON A SURFACE OF A SUBSTRATE USING SAID COMPOSITION | UNIVERSITÉ DE HAUTE ALSACE (FR) | 2016-07-06 | — | — | EP | claimed |
| EP-1311589-A1 | COPOLYMER SEALANT COMPOSITIONS AND METHOD FOR MAKING | GENERAL ELECTRIC COMPANY (US) | 2003-05-21 | — | — | EP | claimed |
| US-20030072951-A1 | Substrate for immobilizing physiological material, and method of fabricating same | SAMSUNG SDI CO., LTD. (KR) | 2003-04-17 | — | — | US | claimed |
| US-20030062263-A1 | Sensors with variable response behavior | HRL LABORATORIES, LLC | 2003-04-03 | — | — | US | claimed |
| EP-1291655-A2 | Substrate for immobilizing physiological material and method of fabricating same | Samsung SDI Co., Ltd. (KR) | 2003-03-12 | — | — | EP | claimed |
| US-20030009000-A1 | Copolymer sealant compositions and method for making | MOMENTIVE PERFORMANCE MATERIALS INC. | 2003-01-09 | — | — | US | claimed |
| US-6451954-B1 | COPOLYMER FROM 1,4-BIS(DIMETHYLHYDROXYSILYL)BENZENE AND TRIS((TRIFLUOROPROPYL)METHYL)CYCLOSILOXANE WITH CROSSLINKING AGENT AND CONDENSATION CATALYST | GENERAL ELECTRIC COMPANY | 2002-09-17 | — | — | US | claimed |
| WO-2002010258-A1 | COPOLYMER SEALANT COMPOSITIONS AND METHOD FOR MAKING | GENERAL ELECTRIC COMPANY (US) | 2002-02-07 | — | — | WO | claimed |
| US-6331500-B1 | SHAPE-SELECTIVE ADSORBENTS AND CATALYSTS MODULATED WITH CROSSLINKED SILOXY MONOMERS; MICROPOROSITY | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2001-12-18 | — | — | US | claimed |
| EP-1069081-A2 | Silicate material and process for fabricating silicate material | LUCENT TECHNOLOGIES INC. (US) | 2001-01-17 | — | — | EP | claimed |
| WO-1999010277-A1 | FUNCTIONALIZED MOLECULAR SIEVES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1999-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240059961-A1 | BIOCOMPATIBLE OXYGEN-SENSITIVE MATERIALS | COXFA4L2, LOXL1, LOX | ESR1 1005/4885PDCD1 4606/4885ESR2 1227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.